🕒 Tuesday 21 July 2026 Tue, 21 July 2026

Babylon Pump & Power has initiated a $12.7 million rights issue at a 37.5% discount to restore working capital, reduce debt, and expand its water management rental fleet, aiming to lift its ASX trading suspension.

The Takeovers Panel has received an application alleging undisclosed associations and possible breaches of takeover laws following a massive off-market transfer of Adslot shares valued at $723,870.

Ceretas Limited is raising $8 million through an IPO to fund clinical trials and development of its novel therapeutic ultrasound device targeting Alzheimer’s disease symptoms.

CONNEQT Health's June quarter saw record consumer revenue growth and a 70% jump in enterprise subscription ARR, supported by a $5.5 million placement and progress on its FDA regulatory pathway for its cloud-based vascular analytics platform.

Lotus Resources confirms material operational setbacks at Kayelekera uranium project, including acid plant damage and production delays impacting offtake commitments. The company remains suspended pending critical funding arrangements.

IDT Australia boosts its FY26 revenue guidance to $16.8 million, anticipating a substantial narrowing of EBITDA losses to under $1 million, driven by strong demand and cost efficiencies.

Triangle Energy (ASX:TEG) and its key subsidiaries have appointed a voluntary administrator amid financial pressures linked to offshore decommissioning obligations. The move follows similar steps by related operators and signals ongoing regulatory and creditor negotiations ahead.

Terrain Minerals (ASX: TMX) delivered a strong June quarter update, confirming high-grade gold and silver mineralisation at its Smokebush flagship, progressing a maiden resource estimate at Lightning, and reporting broad rare earth and lithium anomalies at Lort River and Carlindie projects.

Recce Pharmaceuticals secured a non-binding term sheet with a major Middle Eastern pharma for its diabetic foot infection treatment and raised A$4 million to fund pivotal Phase 3 trials in Australia and Indonesia.

Lumos Diagnostics is accelerating the rollout of its rapid FebriDx test in the US, with a top 100 urgent care group deploying across 30+ sites and three tier 1 groups validating the test across 230+ locations.

Flagship Minerals has received full payment of US$4 million for its RK Lithium Project sale, advancing its strategic pivot towards gold and copper assets in Chile and Canada.

Beacon Minerals has paid a fully franked cash dividend of $0.10 per share, totalling approximately $11.63 million, as part of a broader shareholder return that includes an upcoming in-specie share distribution of Forrestania Resources.

Canterbury Resources is pushing ahead with a large-scale drilling program at its Briggs Copper Project while integrating its newly acquired Monto Project, setting the stage for a Pre-Feasibility Study on a potential tier-one copper operation.

Lode Resources has resumed drilling at its Montezuma Silver & Antimony Project in Tasmania, aiming to expand its 8.2Moz AgEq resource and explore a newly identified silver-zinc lode nearby.

Biotron has received pivotal regulatory feedback from the European Medicines Agency ruling out a Hybrid Marketing Authorisation for SedRx, prompting plans for pivotal clinical trials. The company also advances its lead antiviral candidate BIT-HBV001 against Hepatitis Delta Virus and appoints a new chairman.

Silver Mines has confirmed robust economics for its Bowdens Silver Project, boosting ore reserves to 93.5 million ounces and outlining a 26-year mine life with a $455 million capital cost estimate.

Patagonia Lithium has reached 200 metres depth at Cilon Well 8, reporting strong brine flow rates and specific gravity readings indicative of lithium presence, while confirming no environmental impact from drilling activities.

EV Resources has successfully commissioned the flotation circuit at its Tecomatlán plant, setting the stage for processing bulk ore and producing its first marketable antimony concentrate as it advances toward commercial production.

PEXA contested IPART’s regulatory approach to setting its Initial Asset Base during a public hearing, warning that the proposed valuation could jeopardise its financial sustainability and operational stability.

Golden Dragon Mining has uncovered expansive gold-in-soil anomalies stretching over three kilometres at its Cue Gold Project, signalling a potentially larger mineralised system in Western Australia’s Murchison Goldfields.

Control Bionics has closed its Share Purchase Plan, raising $256,500 and pushing total capital raised to $9.75 million, pending shareholder approval for the final tranche.

WAM Income Maximiser (ASX: WMX) has lifted its fully franked monthly dividends for Q4 2026, pushing the annualised yield to 7.1% including franking credits, supported by a robust 17.8% per annum portfolio return since inception and notably lower volatility than the ASX 300.

Orbminco has completed key drilling and metallurgical milestones at Majestic North, keeping its development timeline on track for a September Mining Development and Closure Proposal lodgement and final investment decision.

Koonenberry Gold Limited has locked in $4 million through a share placement to accelerate drilling and geochemical studies across its NSW projects, including the newly acquired Gundagai.